AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
Pre-Market: 20:00
AgeX Therapeutics Enterprise Value: 29.47M for March 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 26, 2024 | 29.47M |
| March 25, 2024 | 33.22M |
| March 22, 2024 | 34.30M |
| March 21, 2024 | 34.95M |
| March 20, 2024 | 34.25M |
| March 19, 2024 | 38.05M |
| March 18, 2024 | 43.98M |
| March 15, 2024 | 57.53M |
| March 14, 2024 | 1.579B |
| March 13, 2024 | 1.301B |
| March 12, 2024 | 1.408B |
| March 11, 2024 | 1.078B |
| March 08, 2024 | 1.177B |
| March 07, 2024 | 1.177B |
| March 06, 2024 | 1.208B |
| March 05, 2024 | 1.214B |
| March 04, 2024 | 1.216B |
| March 01, 2024 | 1.146B |
| February 29, 2024 | 1.180B |
| February 28, 2024 | 1.149B |
| February 27, 2024 | 1.207B |
| February 26, 2024 | 1.148B |
| February 23, 2024 | 1.146B |
| February 22, 2024 | 1.146B |
| February 21, 2024 | 1.146B |
| Date | Value |
|---|---|
| February 20, 2024 | 1.230B |
| February 16, 2024 | 1.208B |
| February 15, 2024 | 1.239B |
| February 14, 2024 | 1.217B |
| February 13, 2024 | 1.143B |
| February 12, 2024 | 1.186B |
| February 09, 2024 | 1.199B |
| February 08, 2024 | 1.119B |
| February 07, 2024 | 1.110B |
| February 06, 2024 | 1.237B |
| February 05, 2024 | 1.255B |
| February 02, 2024 | 1.258B |
| February 01, 2024 | 1.295B |
| January 31, 2024 | 548.96M |
| January 30, 2024 | 535.61M |
| January 29, 2024 | 537.08M |
| January 26, 2024 | 552.96M |
| January 25, 2024 | 535.61M |
| January 24, 2024 | 538.28M |
| January 23, 2024 | 528.94M |
| January 22, 2024 | 548.96M |
| January 19, 2024 | 535.61M |
| January 18, 2024 | 538.82M |
| January 17, 2024 | 538.82M |
| January 16, 2024 | 531.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.47M
Minimum
Mar 26 2024
5.193B
Maximum
Jun 24 2019
1.462B
Average
1.142B
Median
Aug 16 2023
Enterprise Value Benchmarks
| Homology Medicines Inc (DELISTED) | -79.63M |
| NovaBay Pharmaceuticals Inc | 3.155M |
| Palatin Technologies Inc | 23.39M |
| iBio Inc | 28.05M |
| Theriva Biologics Inc | -11.07M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.401M |
| Revenue (Quarterly) | 0.046M |
| Total Expenses (Quarterly) | 2.402M |
| EPS Diluted (Quarterly) | -4.924 |
| Gross Profit Margin (Quarterly) | 73.91% |
| Profit Margin (Quarterly) | -11.74K% |
| Earnings Yield | -120.4% |
| Normalized Earnings Yield | -120.07 |